SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Residual risk of transfusion‐transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy
7 references·12 citing·37 second hop
Residual risk of transfusion‐transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy (2005)Residual risk of transfusion‐transmitted …Trends in residual risk of transfusion‐transmitted viral infections in France between 1992 and 2000 (2002)Trends in residual risk of tr…International application of the Incidence Rate/Window Period model (2002)International application of …Estimated risk of transfusion‐transmitted viral infections in Spain (2002)Estimated risk of transfusion…Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood (2000)Prospective investigation of …Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases (2000)Nucleic acid amplification te…Blood Feuds (1999)Blood FeudsThe Risk of Transfusion-Transmitted Viral Infections (1996)The Risk of Transfusion-Trans…Trends and epidemiological analysis of hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and human T-cell lymphotropic virus among Iranian blood donors: strategies for improving blood safety (2020)Trends and epidemiological an…Seroprevalence and Trend of HBV, HCV, and HIV Infections among Blood Donors of Fars Province, Iran (2006-2018) (2020)Seroprevalence and Trend of H…Prevalence, incidence and residual risk of transfusion-transmitted hepatitis C virus and human immunodeficiency virus after the implementation of nucleic acid testing in Italy: a 7-year (2009-2015) survey. (2018)Prevalence, incidence and res…Seroepidemiological Study of Hepatitis B, C and HIV among Blood Donors in Kerman (2017)Seroepidemiological Study of …Incidence and Residual Risk of HIV, HBV and HCV Infections Among Blood Donors in Tehran (2016)Incidence and Residual Risk o…Residual Risk of Hepatitis-B-Infected Blood Donations: Estimation Methods and Perspectives (2013)Residual Risk of Hepatitis-B-…Trends in prevalence, incidence, and residual risk of major transfusion‐transmissible viral infections in United Arab Emirates blood donors: impact of individual‐donation nucleic acid testing, 2004 through 2009 (2012)Trends in prevalence, inciden…Risk factors of viral hepatitis: Yet to explore (2012)Risk factors of viral hepatit…Hepatitis B and residual risk of infection in English and Welsh blood donors, 1996 through 2008 (2011)Hepatitis B and residual risk…The first data from the haemovigilance system in Italy. (2007)The first data from the haemo…Residual infectious disease risk in screened blood transfusion from a high‐prevalence population: Santa Catarina, Brazil (2007)Residual infectious disease r…Detection of HIV‐1 infection in blood donors during the immunological window period using the nucleic acid‐amplification technology (2007)Detection of HIV‐1 infection …Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996 (2000)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Nucleic A cid T echnology ( NAT ) testing for blood screening: impact of individual donation and M ini P ool – NAT testing on analytical sensitivity, screening sensitivity and clinical sensitivity (2014)Seroprevalence of transfusion-transmissible infectious agents among volunteer blood donors between 2006 and 2012 in Zhejiang, China. (2015)Status of blood transfusion in World Health Organization-Eastern Mediterranean Region (WHO-EMR): Successes and challenges (2017)Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)NAT of the United States and Canadian blood supply (2000)Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States (2004)Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors. (2008)Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)Effect of a National Disaster on Blood Supply and Safety (2003)Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. (2003)Motivations to donate blood: demographic comparisons (2002)The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations (2003)Undisclosed human immunodeficiency virus risk factors identified through a computer‐based questionnaire program among blood donors in B razil (2013)Use of quality rapid diagnostic testing for safe blood transfusion in resource-limited settings (2013)Seroprevalence and trends of transfusion transmitted infections at Harar blood bank in Harari regional state, Eastern Ethiopia: eight years retrospective study (2018)10.1016/s0000-0000(03)47688-2 (2000)Risque résiduel de transmission du VIH, du VHC et du VHB par transfusion sanguine entre 1992 et 2002 en France et impact du dépistage génomique viral (2004)Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing (2005)Multicenter performance evaluation of a transcription‐mediated amplification assay for screening of human immunodeficiency virus‐1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations (2005)The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection (1997)Health and economic impact of posttransfusion hepatitis B and cost‐effectiveness analysis of expanded HBV testing protocols of blood donors: a study focused on the European Union (2003)Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010 (2012)Transmission of Retroviruses by Transfusion of Screened Blood in Patients Undergoing Cardiac Surgery (1989)The Risk of Transfusion-Transmitted Infection (1992)An estimate of the current risk of transmitting blood‐borne infections through blood transfusion in Italy (2002)Residual risk of transfusion‐transmitted HCV and HIV infections by antibody‐screened blood in Italy (2002)Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6‐year survey (2008)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Evolution of the residual risk of HBV, HCV and HIV transmission through blood transfusion in the Region of Valencia, Spain, during a 15-year period (2003-2017). (2019)Risks and challenges of HIV infection transmitted via blood transfusion (2019)Transfusion Transmissible Infections in Blood Donors in the Province of Bié, Angola, during a 15-Year Follow-Up, Imply the Need for Pathogen Reduction Technologies (2021)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)NAT and blood safety: what is the paradigm? (2000)Modern Costing Innovations and Legitimation: A Health Care Study (2004)Introduction: blood will out (2013)
this work references cited by second hop

References

  • 1996The Risk of Transfusion-Transmitted Viral Infections1,865 cited
  • 2000Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases218 cited
  • 2002International application of the Incidence Rate/Window Period model150 cited
  • 2000Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood101 cited
  • 2002Trends in residual risk of transfusion‐transmitted viral infections in France between 1992 and 200098 cited
  • 1999Blood Feuds89 cited
  • 2002Estimated risk of transfusion‐transmitted viral infections in Spain69 cited

Cited by

  • 2007Residual infectious disease risk in screened blood transfusion from a high‐prevalence population: Santa Catarina, Brazil44 cited
  • 2018Prevalence, incidence and residual risk of transfusion-transmitted hepatitis C virus and human immunodeficiency virus after the implementation of nucleic acid testing in Italy: a 7-year (2009-2015) survey.39 cited
  • 2012Trends in prevalence, incidence, and residual risk of major transfusion‐transmissible viral infections in United Arab Emirates blood donors: impact of individual‐donation nucleic acid testing, 2004 through 200936 cited
  • 2007The first data from the haemovigilance system in Italy.18 cited
  • 2011Hepatitis B and residual risk of infection in English and Welsh blood donors, 1996 through 200816 cited
  • 2017Seroepidemiological Study of Hepatitis B, C and HIV among Blood Donors in Kerman

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

16 cited
  • 2012Risk factors of viral hepatitis: Yet to explore15 cited
  • 2020Trends and epidemiological analysis of hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and human T-cell lymphotropic virus among Iranian blood donors: strategies for improving blood safety13 cited
  • 2007Detection of HIV‐1 infection in blood donors during the immunological window period using the nucleic acid‐amplification technology13 cited
  • 2016Incidence and Residual Risk of HIV, HBV and HCV Infections Among Blood Donors in Tehran7 cited
  • 2013Residual Risk of Hepatitis-B-Infected Blood Donations: Estimation Methods and Perspectives7 cited
  • 2020Seroprevalence and Trend of HBV, HCV, and HIV Infections among Blood Donors of Fars Province, Iran (2006-2018)6 cited